亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

天津法莫西醫藥科技有限公司  

主要開發和經營的方向有抗腫瘤、心腦血管、糖尿病、免疫抑制劑、抗凝血等幾大類原料藥及其關鍵中間體

搜索
新聞中心
  • 暫無新聞
產品分類
聯系方式
  • 聯系人:朱文玲
  • 電話:022-23359620
  • 郵件:zhu.wenling@pharmacn.com
  • 傳真:022-23377103
  • QQ:1339732154
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 162-44-7 4-溴-1-丁烯
162-44-7 4-溴-1-丁烯
單價 面議對比
詢價 暫無
發貨 天津付款后3天內
庫存 1000kg起訂1kg
品牌 黃金產品
型號 5162-44-7
規格 98%
過期 長期有效
更新 2015-09-23 13:40
 
詳細信息

中文名稱: 4-溴-1-丁烯
中文同義詞: 4-溴-1-丁烯;4-溴-1-丁烯,97%;3-丁烯基溴;4-溴丁烯
英文名稱: 4-Bromo-1-butene
英文同義詞: 1-Bromo-3-butene;1-butene,4-bromo-;4-bromo-1-buten;4-bromo-but-1-ene;4-bromobut-1-ene;4-Bromobutene;4-Bromobutene-(1);Homoallyl bromide
CAS號: 5162-44-7
分子式: C4H7Br
分子量: 135
EINECS號: 225-937-4
相關類別: 鹵化物;烯、醇、酚、醚;專業烯烴;Halides;omega-Functional Alkanols, Carboxylic Acids, Amines & Halides;omega-Unsaturated Halides;Alkenyl;Halogenated Hydrocarbons;Organic Building Blocks
Mol文件: 5162-44-7.mol
4-溴-1-丁烯
 
4-溴-1-丁烯 性質
沸點  98-100 °C(lit.)
密度  1.33 g/mL at 25 °C(lit.)
折射率  n20/D 1.462(lit.)
閃點  49 °F
儲存條件  2-8°C
敏感性  Light Sensitive
BRN  1098377
穩定性 Stable. Incompatible with strong bases, strong oxidizing agents. Highly flammable. Light sensitive.
©2025 天津法莫西醫藥科技有限公司 版權所有   技術支持:化工網   訪問量:23353  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |